Decrease of the platelet 5-HT2A receptor function by long-term imipramine treatment in endogenous depression

Human Psychopharmacology

Volumn 19, Issue 4, 2004, Pages 251-258

  Gómez Gil, Esther ^a   Gastó, Cristóbal ^a   Carretero, Marta ^b   Díaz Ricart, Maribel ^b   Salamero, Manel ^a   Navinés, Ricard ^a   Escolar, Ginés ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

5 HT2A receptor; Antidepressant treatment; Endogenous; Imipramine; Major depression; Platelet aggregation; Serotonin

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; IMIPRAMINE; LORAZEPAM; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN; SEROTONIN 2A RECEPTOR; THROMBOCYTE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENDOGENOUS DEPRESSION; FEMALE; HUMAN; LONG TERM CARE; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RATING SCALE; REMISSION; STATISTICAL SIGNIFICANCE; THROMBOCYTE AGGREGATION;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BLOOD PLATELETS; DEPRESSIVE DISORDER, MAJOR; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMIPRAMINE; MALE; PLATELET AGGREGATION; RECEPTOR, SEROTONIN, 5-HT2A;

EID: 18544397724     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.583     Document Type: Article

References (50)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press: Washington, DC.
2. Bakish D, Cavazzoni P, Chudzik J, Ravindran A, Hrdina PD. 1997. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol Psychiatry 41: 184-190.
3. Berk M, Mitchell VS, Plein H. 1998. The platelet intracellular calcium response to serotonin in subsyndromal depression. Int Clin Psychopharmacol 13: 107-110.
4. 2 receptor binding in blood platelets - a peripheral marker for depression? Life Sci 41: 2485-2492.
5. Blier P, de Montigny C. 1994. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15: 220-226.
6. Born GVR. 1962. Aggregation of blood platelets by ADP and its reversal. Nature 194: 927-929.
7. Brusov OS, Beliaev BS, Katasonov AB, Zlobina GP, Factor MI, Lideman RR. 1989. Does platelet serotonin supersensitivity accompany endogenous depression? Biol Psychiatry 25: 375-381.
8. Butler J, Leonard BE. 1988. The platelet serotonergic system in depression and following sertraline treatment. Int Clin Psychopharmacol 3: 343-347.
9. Camacho A, Dimsdale JE. 2000. Platelets and psychiatry: lessons learned from old and new studies. Psychosom Med 62: 326-336.
10. Carney MWP, Roth M, Garside RF. 1965. The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatry 111: 659-674.
11. 2-receptors and serotonin release: their role in human platelet aggregation. Life Sci 53: 209-215.
12. Corona GL, Cucchi ML, Santagostino G, et al. 1982. Blood noradrenaline and 5-HT levels in depressed women during amitriptyline or lithium treatment. Psychopharmacology (Berl) 77: 236-241.
13. Cowen PJ, Charing EM, Fraser S, Elliot JM. 1987. Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment. J Affect Disord 13: 45-50.
14. De Boer T. 1995. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission, Int Clin Psychopharmacol 10(Suppl 4): 19-23.
15. Delisi SM, Konopka LM, O'Connor FL, Crayton JW. 1998. Platelet cytosolic calcium responses to serotonin in depressed patients and controls: relationship to symptomatology and medication. Biol Psychiatry 43: 327-334.
16. 2 receptor stimulation in platelets of depressed patients. Biol Psychiatry 34: 565-568.
17. Gómez E, Carretero M, Escolar G, Salamero M, Gastó C. 1997. Agregación plaquetaria con serotonina como método indirecto de función serotoninérgica. Rev Psiquiatrí a Fac Med Barna (España) 24: 77-81.
18. 2A receptor-mediated induction of aggregation is not altered in major depression. Hum Psychopharmacol Clin Exp 17: 419-424.
19. Goodnough DB, Baker GB. 1994. 5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. J Neurochem 62: 2262-2268.
20. 2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br J Pharmacol 83: 235-242.
21. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
22. Healy D, Carney PA, O'Halloran A, Leonard BE. 1985. Peripheral adrenoceptors and serotonin receptors in depression. J Affect Disord 9: 285-296.
23. 2A receptors unchanged by antidepressant treatment. Psychiatry Res 66: 73-85.
24. 2 receptors in rat brain: an autoradiographic study. Synapse 14: 324-331.
25. Kellar KJ, Cascio CS, Butler JA, Kurtzkem RN. 1981. Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur J Pharmacol 69: 515-518.
26. Kendall DA, Nahorski SR. 1985. 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants. J Pharmacol Exp Ther 233: 473-479.
27. 2 receptors in the rat brain. J Psychiatry Neurosci 19: 63-67.
28. 2+ response is increased in the blood platelets of depressed patients. Biol Psychiatry 30: 310-312.
29. Malik K. 1996. Nefazodone: structure, mode of action and pharmacokinetics. J Psychopharmacol 10(Suppl 1): 1-4.
30. McAdams C, Leonard BE. 1992. Changes in platelet aggregatory responses to collagen and 5-hydroxytryptamine in depressed, schizophrenic and manic patients, Int Clin Psychopharmacol 7: 81-85.
31. 2 receptor indices to major depressive disorder, personality traits, and suicidal behaviour. Biol Psychiatry 35: 295-308.
32. 2 receptor on human platelets. Life Sci 40: 1799-1809.
33. Meltzer HY, Lowy M, Robertson A, Goodnick P, Perline R. 1984. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders - III: effect of antidepressants and lithium carbonate. Arch Gen Psychiatry 41: 391-397.
34. 18F] setoperone PET imaging study. Am J Psychiatry 158: 78-85.
35. Naughton M, Mulrooney JB, Leonard BE. 2000. A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol Clin Exp 15: 397-415.
36. Nugent DF, Dinan TG, Leonard BE. 1994. Alteration by a plasma factor(s) of platelet aggregation in unmedicated unipolar depressed patients. J Affect Disord 31: 61-66.
37. Pandey SC, Davis JM, Pandey GN. 1995. Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates. J Psychiatry Neurosci 3: 215-225.
38. Pei Q, Zetterstrom T, Fillenz M. 1989. Both systemic and local administration of benzodiazepine agonists inhibit the in vivo release of 5-HT from ventral hippocampus. Neuropharmacology 28: 1061-1066.
39. Peroutka SJL, Snyder SH. 1980. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210: 88-90.
40. Plein H, Berk M. 2001. The platelet as a peripheral marker in psychiatric illness. Hum Psychopharmacol Clin Exp 16: 229-236.
41. Sanders-Bush E, Breeding M, Knoth K, Tsutsumi M. 1989. Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system. Psychopharmacology (Berl) 99: 64-69.
42. Sarrias MJ, Artigas F, Martínez E, et al. 1987. Decreased plasma serotonin in melancholic patients: a study with clomipramine. Biol Psychiatry 22: 1429-1438.
43. 125I]-DOI. Eur Psychiatry 14: 451-457.
44. Shapira B, Reiss A, Kalser N, Kindler S, Lerer B. 1989. Effect of imipramine treatment on the prolactin response to fenfluramine and placebo challenge in depressed patients. J Affect Disord 16: 1-4.
45. Stahl SM. 1992. The current impact of neuroscience on psychotropic drug discovery and development. Psychopharmacol Bull 28: 3-9.
46. 1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs? Psychopharmacol Bull 30: 39-43.
47. Stahl SM, Hauger RL, Rausch JL, Fleishaker JC, Hubbell-Alberts EA. 1993. Down regulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers. Clin Neuropharmacol 16: 519-531.
48. Vanags DM, Rodgers SE, Duncan EM, Lloyd JV, Bochner F. 1992. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline. Br J Pharmacol 106: 917-923.
49. Wirz-Justice A. 1988. Platelet research in psychiatry. Experientia 44: 145-151.
50. 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone. Arch Gen Psychiatry 56: 705-711.